Who Paid My Doc Search
Menu
Product Program year 2020 Source: CMS Open Payments

Proleukin

Drug Metastatic Renal Cell Carcinoma or Melanoma

NDC 65483-116-07

Open in the dashboard

General payments

$44,871

160 payments

Research payments

$8,019,054

24 payments

Through program year 2020, $44,871 in general payments and $8,019,054 in research payments were reported against Proleukin (Metastatic Renal Cell Carcinoma or Melanoma).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2020 General $37,772 63
2020 Research $4,815,798 11
2019 General $7,100 97
2019 Research $3,203,256 13

Breakdown

Who paid General payments · program years 2019–2020
  1. Clinigen Inc $44,871 160 payments
Top recipients General payments · program year 2020
  1. Brendan Curti Medical Oncology · Portland, OR $6,225 16% · 3 payments
  2. Harriet Kluger Medical Oncology · New Haven, CT $5,250 14% · 2 payments
  3. Gerald Miletello Medical Oncology · Baton Rouge, LA $4,804 13% · 3 payments
  4. Roberto Pili Medical Oncology · Williamsville, NY $4,725 13% · 2 payments
  5. Gregory Daniels Hematology & Oncology · San Diego, CA $4,200 11% · 2 payments

The top 5 of 52 recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Medical Oncology Internal Medicine $25,978 69% · 9 practitioners
  2. Hematology & Oncology Internal Medicine $11,091 29% · 8 practitioners
  3. Urology $469 1% · 27 practitioners
  4. Surgical Oncology Surgery $105 <1% · 1 practitioner
  5. Radiation Oncology Radiology $51 <1% · 3 practitioners

The top 5 of 8 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2020
  1. Oregon $6,225 16% · 1 recipient
  2. Connecticut $5,250 14% · 1 recipient
  3. Louisiana $4,870 13% · 5 recipients
  4. Indiana $4,811 13% · 7 recipients
  5. California $4,238 11% · 3 recipients

The top 5 of 17 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

Records

160 general · 24 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record